|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan C, Qian X, Guan Z, Yang B, Ge Y, Wang
F and Cai J: Potential biomarkers for esophageal cancer.
Springerplus. 5:4672016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kang X, Chen K, Li Y, Li J, D'Amico TA and
Chen X: Personalized targeted therapy for esophageal squamous cell
carcinoma. World J Gastroenterol. 21:7648–7658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Makarova JA, Shkurnikov MU, Wicklein D,
Lange T, Samatov TR, Turchinovich AA and Tonevitsky AG:
Intracellular and extracellular microRNA: An update on localization
and biological role. Prog Histochem Cytochem. 51:33–49. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yan X, Xu H and Yan Z: Functional
perspective and implications of gene expression by noncoding RNAs.
Cancer Transl Med. 1:137–152. 2015. View Article : Google Scholar
|
|
8
|
Svoronos AA, Engelman DM and Slack FJ:
OncomiR or tumor suppressor? The duplicity of microRNAs in cancer.
Cancer Res. 76:3666–3670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rupaimoole R, Calin GA, Lopez-Berestein G
and Sood AK: miRNA deregulation in cancer cells and the tumor
microenvironment. Cancer Discov. 6:235–246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu W, Li M, Chen X, Zhang D, Wei L, Zhang
Z, Wang S, Meng L, Zhu S and Li B: MicroRNA-373 promotes migration
and invasion in human esophageal squamous cell carcinoma by
inhibiting TIMP3 expression. Am J Cancer Res. 6:1–14.
2015.PubMed/NCBI
|
|
11
|
Nie J, Ge X, Geng Y, Cao H, Zhu W, Jiao Y,
Wu J, Zhou J and Cao J: miR-34a inhibits the migration and invasion
of esophageal squamous cell carcinoma by targeting Yin Yang-1.
Oncol Rep. 34:311–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao Y, Liu J, Zhang D and Li B: MiR-1290
promotes cancer progression by targeting nuclear factor I/X(NFIX)
in esophageal squamous cell carcinoma (ESCC). Biomed Pharmacother.
76:82–93. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang Y, Zhang Y, Li F, Du X and Zhang J:
CDX2 inhibits pancreatic adenocarcinoma cell proliferation via
promoting tumor suppressor miR-615-5p. Tumour Biol. 37:1041–1049.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao W, Gu Y, Li Z, Cai H, Peng Q, Tu M,
Kondo Y, Shinjo K, Zhu Y, Zhang J, et al: miR-615-5p is
epigenetically inactivated and functions as a tumor suppressor in
pancreatic ductal adenocarcinoma. Oncogene. 34:1629–1640. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song LJ, Zhang WJ, Chang ZW, Pan YF, Zong
H, Fan QX and Wang LXPU: PU.1 is identified as a novel metastasis
suppressor in hepatocellular carcinoma regulating the
miR-615-5p/IGF2 axis. Asian Pac J Cancer Prev. 16:3667–3671. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao ZG, Jin JY, Zhang AM, Zhang LP, Wang
XX, Sun JG and Chen ZT: MicroRNA profile of tumorigenic cells
during carcinogenesis of lung adenocarcinoma. J Cell Biochem.
116:458–466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44(D1): D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
El Tayebi HM, Hosny KA, Esmat G, Breuhahn
K and Abdelaziz AI: miR-615-5p is restrictedly expressed in
cirrhotic and cancerous liver tissues and its overexpression
alleviates the tumorigenic effects in hepatocellular carcinoma.
FEBS Lett. 586:3309–3316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gulyaeva LF and Kushlinskiy NE: Regulatory
mechanisms of microRNA expression. J Transl Med. 14:1432016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arora A, Singh S, Bhatt AN, Pandey S,
Sandhir R and Dwarakanath BS: Interplay between metabolism and
oncogenic process: Role of microRNAs. Transl Oncogenomics. 7:11–27.
2015.PubMed/NCBI
|
|
22
|
Sun Y, Zhang T, Wang C, Jin X, Jia C, Yu S
and Chen J: MiRNA-615-5p functions as a tumor suppressor in
pancreatic ductal adenocarcinoma by targeting AKT2. PLoS One.
10:e01197832015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai Y, Li J, Li J, Liu Y and Zhang B:
MiR-615 inhibited cell proliferation and cell cycle of human breast
cancer cells by suppressing of AKT2 expression. Int J Clin Exp Med.
8:3801–3808. 2015.PubMed/NCBI
|
|
24
|
Wu X, Deng L, Tang D, Ying G, Yao X, Liu F
and Liang G: miR-615-5p prevents proliferation and migration
through negatively regulating serine hydromethyltransferase 2
(SHMT2) in hepatocellular carcinoma. Tumour Biol. 37:6813–6821.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brouwer-Visser J and Huang GS: IGF2
signaling and regulation in cancer. Cytokine Growth Factor Rev.
26:371–377. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bruchim I, Sarfstein R and Werner H: The
IGF Hormonal Network in Endometrial Cancer: Functions, regulation,
and targeting approaches. Front Endocrinol (Lausanne).
5:762014.PubMed/NCBI
|
|
27
|
Chao W and D'Amore PA: IGF2: Epigenetic
regulation and role in development and disease. Cytokine Growth
Factor Rev. 19:111–120. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mu Q, Wang L, Yu F, Gao H, Lei T, Li P,
Liu P, Zheng X, Hu X, Chen Y, et al: Imp2 regulates GBM progression
by activating IGF2/PI3K/Akt pathway. Cancer Biol Ther. 16:623–633.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chava S, Mohan V, Shetty PJ, Manolla Ml,
Vaidya S, Khan IA, Waseem GL, Boddala P, Ahuja YR and Hasan Q:
Immunohistochemical evaluation of p53, FHIT, and IGF2 gene
expression in esophageal cancer. Dis Esophagus. 25:81–87. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao T, He B, Pan Y, Xu Y, Li R, Deng Q,
Sun H and Wang S: Long non-coding RNA 91H contributes to the
occurrence and progression of esophageal squamous cell carcinoma by
inhibiting IGF2 expression. Mol Carcinog. 54:359–367. 2015.
View Article : Google Scholar : PubMed/NCBI
|
